InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Kelly Paul Edward, Director. Insider active across 1 companies, notably Relmada Therapeutics, INC.. In total, 3 filings have been published. The latest transaction was disclosed on 4 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€29,51910,000 shares@ €2.95190.0041% mcap20.6% of flow
Common Stock
SEC:0001213900-22-018223:0·
€56,97520,000 shares@ €2.84870.0079% mcap100.0% of flow
Common Stock
SEC:0001213900-22-000761·
€56,97520,000 shares@ €2.84870.0079% mcap39.7% of flow
Common Stock
SEC:0001213900-22-000761:0·
3 of 3 declarations
About Kelly Paul Edward
Paul Edward Kelly is a Board Member of Relmada Therapeutics, Inc., a biotechnology company. As a board member, he participates in overseeing the company's activities and making strategic decisions. His expertise in the biotechnology field is valuable for guiding Relmada's initiatives.
